{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:49:45Z","timestamp":1790660985070,"version":"4.1.0"},"reference-count":38,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"289","license":[{"start":{"date-parts":[[2016,5,27]],"date-time":"2016-05-27T00:00:00Z","timestamp":1464307200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.sciencemag.org\/about\/science-licenses-journal-article-reuse"}],"funder":[{"name":"MacroGenics"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sci. Transl. Med."],"published-print":{"date-parts":[[2015,5,27]]},"abstract":"<jats:p>MGD006, a CD3xCD123 bispecific DART molecule intended for AML treatment, shows anticancer activity in mouse model and favorable pharmacodynamic and safety profile in nonhuman primates.<\/jats:p>","DOI":"10.1126\/scitranslmed.aaa5693","type":"journal-article","created":{"date-parts":[[2015,5,28]],"date-time":"2015-05-28T11:10:19Z","timestamp":1432811419000},"source":"Crossref","is-referenced-by-count":154,"title":["A CD3xCD123 bispecific DART for redirecting host T cells to myelogenous leukemia: Preclinical activity and safety in nonhuman primates"],"prefix":"10.1126","volume":"7","author":[{"given":"Gurunadh R.","family":"Chichili","sequence":"first","affiliation":[{"name":"MacroGenics Inc., 9640 Medical Center Drive, Rockville, MD 20850, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Huang","sequence":"additional","affiliation":[{"name":"MacroGenics Inc., 9640 Medical Center Drive, Rockville, MD 20850, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Li","sequence":"additional","affiliation":[{"name":"MacroGenics Inc., 9640 Medical Center Drive, Rockville, MD 20850, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Burke","sequence":"additional","affiliation":[{"name":"MacroGenics Inc., 9640 Medical Center Drive, Rockville, MD 20850, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leilei","family":"He","sequence":"additional","affiliation":[{"name":"MacroGenics Inc., 9640 Medical Center Drive, Rockville, MD 20850, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Tang","sequence":"additional","affiliation":[{"name":"MacroGenics Inc., 9640 Medical Center Drive, Rockville, MD 20850, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Jin","sequence":"additional","affiliation":[{"name":"MacroGenics Inc., 9640 Medical Center Drive, Rockville, MD 20850, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Gorlatov","sequence":"additional","affiliation":[{"name":"MacroGenics Inc., 9640 Medical Center Drive, Rockville, MD 20850, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Ciccarone","sequence":"additional","affiliation":[{"name":"MacroGenics Inc., 9640 Medical Center Drive, Rockville, MD 20850, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francine","family":"Chen","sequence":"additional","affiliation":[{"name":"MacroGenics Inc., 9640 Medical Center Drive, Rockville, MD 20850, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Koenig","sequence":"additional","affiliation":[{"name":"MacroGenics Inc., 9640 Medical Center Drive, Rockville, MD 20850, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Shannon","sequence":"additional","affiliation":[{"name":"MacroGenics Inc., 9640 Medical Center Drive, Rockville, MD 20850, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Alderson","sequence":"additional","affiliation":[{"name":"MacroGenics Inc., 9640 Medical Center Drive, Rockville, MD 20850, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Moore","sequence":"additional","affiliation":[{"name":"MacroGenics Inc., 9640 Medical Center Drive, Rockville, MD 20850, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syd","family":"Johnson","sequence":"additional","affiliation":[{"name":"MacroGenics Inc., 9640 Medical Center Drive, Rockville, MD 20850, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezio","family":"Bonvini","sequence":"additional","affiliation":[{"name":"MacroGenics Inc., 9640 Medical Center Drive, Rockville, MD 20850, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","reference":[{"key":"e_1_3_2_2_2","first-page":"1261","article-title":"Interleukin-3 receptor \u03b1 chain (CD123) is widely expressed in hematologic malignancies","volume":"86","author":"Mu\u00f1oz L.","year":"2001","unstructured":"Mu\u00f1oz L., Nomded\u00e9u J. F., L\u00f3pez O., Carnicer M. J., Bellido M., Avent\u00edn A., Brunet S., Sierra J., Interleukin-3 receptor \u03b1 chain (CD123) is widely expressed in hematologic malignancies. Haematologica 86, 1261\u20131269 (2001).","journal-title":"Haematologica"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1186\/2050-7771-2-4"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.047894"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401903"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2009.04.018"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.085209"},{"key":"e_1_3_2_8_2","first-page":"1","article-title":"A Phase 1 study of the safety, pharmacokinetics and anti-leukemic activity of the anti-CD123 monoclonal antibody CSL360 in relapsed, refractory or high-risk acute myeloid leukemia","author":"He S. Z.","year":"2014","unstructured":"He S. Z., Busfield S., Ritchie D. S., Hertzberg M. S., Durrant S., Lewis I. D., Marlton P., McLachlan A. J., Kerridge I., Bradstock K. F., Kennedy G., Boyd A. W., Yeadon T. M., Lopez A. F., Ramshaw H. S., Iland H., Bamford S., Barnden M., DeWitte M., Basser R., Roberts A. W., A Phase 1 study of the safety, pharmacokinetics and anti-leukemic activity of the anti-CD123 monoclonal antibody CSL360 in relapsed, refractory or high-risk acute myeloid leukemia. Leuk. Lymphoma 1\u201310 (2014).","journal-title":"Leuk. Lymphoma"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/icb.1996.1"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-01-400515"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-07-441030"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.7270"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1407222"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2010.04.001"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-09-306449"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M204257200"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-03-491506"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-04-495366"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-14-0105"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-04-493916"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1158545"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1116110108"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2013.01.027"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1080\/10428190500272507"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.20561"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-08-523548"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-09-527044"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-02-206946"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/protein\/gzs040"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0198-8859(89)90097-9"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2035"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-09-529537"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-12-474056"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.62"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12282"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.128"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08300.x"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1080\/10428190701799035"},{"key":"e_1_3_2_39_2","unstructured":"L. Huang L. S. Johnson CD3-binding molecules capable of binding to human and non-human CD3 U.S. Patent. 20140099318 (2014)."}],"container-title":["Science Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/scitranslmed.aaa5693","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T17:57:43Z","timestamp":1705427863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/scitranslmed.aaa5693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,27]]},"references-count":38,"journal-issue":{"issue":"289","published-print":{"date-parts":[[2015,5,27]]}},"alternative-id":["10.1126\/scitranslmed.aaa5693"],"URL":"https:\/\/doi.org\/10.1126\/scitranslmed.aaa5693","relation":{},"ISSN":["1946-6234","1946-6242"],"issn-type":[{"value":"1946-6234","type":"print"},{"value":"1946-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,27]]}}}